BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29396293)

  • 21. Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
    Katayama S; Pradere B; Grossman NC; Potretzke AM; Boorjian SA; Ghoreifi A; Daneshmand S; Djaladat H; Sfakianos JP; Mari A; Khene ZE; D'Andrea D; Hayakawa N; Breda A; Fontana M; Fujita K; Antonelli A; van Doeveren T; Steinbach C; Mori K; Laukhtina E; Rouprêt M; Margulis V; Karakiewicz PI; Araki M; Compérat E; Nasu Y; Shariat SF
    Int J Urol; 2023 Jan; 30(1):63-69. PubMed ID: 36349904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
    Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
    World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
    D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
    Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.
    Anbarasan T; Nissar S; Turbitt J; Walls K; McLuckie S; Clark C; Bourdon JC; Tracey J; Bray S; Shamsuddin A; Alcorn J; Jain S; Hislop R; Biyani CS; Nabi G
    Scott Med J; 2023 Feb; 68(1):4-13. PubMed ID: 36576735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies.
    Yakoubi R; Colin P; Seisen T; Léon P; Nison L; Bozzini G; Shariat SF; Rouprêt M
    Eur J Surg Oncol; 2014 Dec; 40(12):1629-34. PubMed ID: 25108813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma.
    Mori K; Katayama S; Laukhtina E; Schuettfort VM; Pradere B; Quhal F; Sari Motlagh R; Mostafaei H; Grossmann NC; Rajwa P; Zimmermann K; Karakiewicz PI; Abufaraj M; Fajkovic H; Rouprêt M; Margulis V; Enikeev DV; Egawa S; Shariat SF
    Clin Genitourin Cancer; 2022 Feb; 20(1):95.e1-95.e6. PubMed ID: 34764007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
    Liu J; Wu P; Lai S; Wang J; Hou H; Zhang Y
    BMC Cancer; 2023 Jun; 23(1):574. PubMed ID: 37349696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of biopsy devices in upper tract urothelial carcinoma.
    Breda A; Territo A; Sanguedolce F; Basile G; Subiela JD; Reyes HV; Ferrer OM; Gaya JM; Palou J
    World J Urol; 2019 Sep; 37(9):1899-1905. PubMed ID: 30560298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach.
    Guarnizo E; Pavlovich CP; Seiba M; Carlson DL; Vaughan ED; Sosa RE
    J Urol; 2000 Jan; 163(1):52-5. PubMed ID: 10604312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial clinical experience with use of ureteral access sheaths in the diagnosis and treatment of upper tract urothelial carcinoma.
    Gorin MA; Santos Cortes JA; Kyle CC; Carey RI; Bird VG
    Urology; 2011 Sep; 78(3):523-7. PubMed ID: 21529901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma.
    Keeley FX; Kulp DA; Bibbo M; McCue PA; Bagley DH
    J Urol; 1997 Jan; 157(1):33-7. PubMed ID: 8976209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.
    Smith AK; Stephenson AJ; Lane BR; Larson BT; Thomas AA; Gong MC; Jones JS; Campbell SC; Hansel DE
    Urology; 2011 Jul; 78(1):82-6. PubMed ID: 21550642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
    Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic management of upper-tract urothelial carcinoma.
    Raman JD; Park R
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):545-554. PubMed ID: 28480774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-institutional Evaluation of Upper Urinary Tract Biopsy Using Backloaded Cup Biopsy Forceps, a Nitinol Basket, and Standard Cup Biopsy Forceps.
    Lama DJ; Safiullah S; Patel RM; Lee TK; Balani JP; Zhang L; Okhunov Z; Margulis V; Savage SJ; Uchio E; Landman J
    Urology; 2018 Jul; 117():89-94. PubMed ID: 29630955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
    Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
    BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.